SEARCH

SEARCH BY CITATION

References

  • Abdel-Malek, Z., Swope, V.B., Suzuki, I., Akcali, C., Harriger, M.D., Boyce, S.T., Urabe, K., and Hearing, V.J. (1995). Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. U.S.A. 92, 17891793.
  • Abdel-Malek, Z.A., Kadekaro, A.L., Kavanagh, R.J. et al. (2006). Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced damage and cytotoxicity. FASEB J. 20, 15611563.
  • Amidon, G.L., and Lee, H.J. (1994). Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 34, 321341.
  • Ananthaswamy, H.N., Loughlin, S.M., Ullrich, S.E., and Kripke, M.L. (1998). Inhibition of UV-induced p53 mutations by sunscreens: implications for skin cancer prevention. J. Investig. Dermatol. Symp. Proc. 3, 5256.
  • Atoyan, R.Y., Sharov, A.A., Eller, M.S., Sargsyan, A., Botchkarev, V.A., and Gilchrest, B.A. (2007). Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Exp. Dermatol. 16, 671677.
  • Barnetson, R.S., Ooi, T.K., Zhuang, L., Halliday, G.M., Reid, C.M., Walker, P.C., Humphrey, S.M., and Kleinig, M.J. (2006). [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J. Invest. Dermatol. 126, 18691878.
  • Benson, H.A., and Namjoshi, S. (2008). Proteins and peptides: strategies for delivery to and across the skin. J. Pharm. Sci. 97, 35913610.
  • Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T., and Schwarz, A. (2005). alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 57955802.
  • Bohm, M., Luger, T.A., Tobin, D.J., and Garcia-Borron, J.C. (2006). Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J. Invest. Dermatol. 126, 19661975.
  • Box, N.F., Wyeth, J.R., O’Gorman, L.E., Martin, N.G., and Sturm, R.A. (1997). Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 18911897.
  • Box, N.F., Duffy, D.L., Chen, W., Stark, M., Martin, N.G., Sturm, R.A., and Hayward, N.K. (2001). MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 69, 765773.
  • Brzoska, T., Luger, T.A., Maaser, C., Abels, C., and Bohm, M. (2008). Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr. Rev. 29, 581602.
  • Bustamante, J., Bredeston, L., Malanga, G., and Mordoh, J. (1993). Role of melanin as a scavenger of active oxygen species. Pigment Cell Res. 6, 348353.
  • Cevc, G. (1997). Drug delivery across the skin. Expert Opin. Investig. Drugs 6, 18871937.
  • Chakraborty, A.K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J.M., and Ichihashi, M. (1996). Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130138.
  • Cui, R., Widlund, H.R., Feige, E. et al. (2007). Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853864.
  • D’Orazio, J.A., Nobuhisa, T., Cui, R. et al. (2006). Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 443, 340344.
  • Epstein, J.H. (1983). Photocarcinogenesis, skin cancer and aging. J. Am. Acad. Dermatol. 9, 487502.
  • Gilchrest, B.A., Eller, M.S., Geller, A.C., and Yaar, M. (1999). The pathogenesis of melanoma induced by ultraviolet radiation. N. Engl. J. Med. 340, 13411348.
  • Halder, R.M., and Bridgeman-Shah, S. (1995). Skin cancer in African Americans. Cancer 75, 667673.
  • Haskell-Luevano, C., Hendrata, S., North, C., Sawyer, T.K., Hadley, M.E., Hruby, V.J., Dickinson, C., and Gantz, I. (1997). Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J. Med. Chem. 40, 21332139.
  • Hauser, J.E., Kadekaro, A.L., Kavanagh, R.J., Wakamatsu, K., Terzieva, S., Schwemberger, S., Babcock, G., Rao, M.B., Ito, S., and Abdel-Malek, Z.A. (2006). Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res. 19, 303314.
  • Hunt, G., Kyne, S., Wakamatsu, K., Ito, S., and Thody, A.J. (1995). Nle4DPhe7α-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes. J. Invest. Dermatol. 104, 8385.
  • Im, S., Moro, O., Peng, F., Medrano, E.E., Cornelius, J., Babcock, G., Nordlund, J., and Abdel-Malek, Z. (1998). Activation of the cyclic AMP pathway by α-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res. 58, 4754.
  • Jois, S.D., Koikov, L., Abdel-Malek, Z.A., Kavanagh, R.J., Wortman, M., and Knittel, J.J. (2009). Conformations of end-capped melanocortin agonists RCO-X-Z-Arg-Trp-NH2 by 2D-NMG, CD and computations. American Peptide Symposium, Bloomington, IN, June 7-12, 2009.
  • Kadekaro, A.L., Kavanagh, R., Kanto, H. et al. (2005). α-Melanocortin and endothelin-1 activate anti-apoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 42924299.
  • Kaidbey, K.H., Poh Agin, P., Sayre, R.M., and Kligman, A.M. (1979). Photoprotection by melanin - a comparison of black and Caucasian skin. J. Am. Acad. Dermatol. 1, 249260.
  • Kennedy, C., Ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R., and Bouwes Bavinck, J.N. (2001). Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294300.
  • Kobayashi, N., Nakagawa, A., Muramatsu, T., Yamashina, Y., Shirai, T., Hashimoto, M.W., Ishigaki, Y., Ohnishi, T., and Mori, T. (1998). Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J. Invest. Dermatol. 110, 806810.
  • Koikov, L.N., Ebetino, F.H., Solinsky, M.G., Cross-Doersen, D., and Knittel, J.J. (2003). Sub-nanomolar hMC1R agonists by end-capping of the melanocortin tetrapeptide His-DPhe-Arg-Trp-NH2. Bioorg. Med. Chem. Lett. 13, 26472650.
  • Koikov, L.N., Ebetino, F.H., Solinsky, M.G., Cross-Doersen, D., and Knittel, J.J. (2004). Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH2)3CO-His-DPhe-Arg-Trp-NH2]. An additional binding site within the human melanocortin receptor 1? Bioorg. Med. Chem. Lett. 14, 39974000.
  • Koikov, L., Ruwe, A.R., Abdel-Malek, Z.A., Haskell-Luevano, C., Dirain, M.L., Portillo, F., Xiang, Z., Wortman, M., and Knittel, J.J. (2009). Semi-rigid MC1 selective agonists based on N-capped His-D-Phe-Arg-NH2 tripeptide core. American Peptide Symposium, Bloomington, IN, June 7-12, 2009.
  • Kraemer, K.H., Lee, M.-M., Andrews, A.D., and Lambert, W.C. (1994). The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130, 10181021.
  • Landi, M.T., Bauer, J., Pfeiffer, R.M., Elder, D.E., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P.A., Pinkel, D., and Bastian, B.C. (2006). MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313, 521522.
  • Lee, V.H. (1988). Enzymatic barriers to peptide and protein absorption. Crit. Rev. Ther. Drug Carrier Syst. 5, 6997.
  • Levine, N., Sheftel, S.N., Eytan, T., Dorr, R.T., Hadley, M.E., Weinrach, J.C., Ertl, G.A., Toth, K., and Hruby, V.J. (1991). Induction of skin tanning by the subcutaneous administration of a potent synthetic melanotropin. JAMA 266, 27302736.
  • MacLennan, R., Green, A.C., McLeod, G.R.C., and Martin, N.G. (1992). Increasing incidence of cutaneous melanoma in Queensland, Australia. J. Natl Cancer Inst. 84, 14271432.
  • Mitragotri, S. (2003). Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control Release 86, 6992.
  • Namjoshi, S., Chen, Y., Edwards, J., and Benson, H.A. (2008). Enhanced transdermal delivery of a dipeptide by dermaportation. Biopolymers 90, 655662.
  • Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O’Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176186.
  • Passeron, T., Namiki, T., Passeron, H.J., Le Pape, E., and Hearing, V.J. (2009). Forskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis. J. Invest. Dermatol. 129, 162166.
  • Pathak, M.A., Hori, Y., Szabo, G., and Fitzpatrick, T.B. (1971). The photobiology of melanin pigmentation in human skin. In Biology of Normal and Abnormal Melanocytes, T.Kawamura, T.B.Fitzpatrick, and M.Seiji, eds. (Baltimore: University Park Press), pp. 149169.
  • Pathak, M.A., Jimbow, K., and Fitzpatrick, T. (1980). Photobiology of pigment cell, In Phenotypic Expression in Pigment Cells, M.Seiji, ed. (Tokyo, Japan: University of Tokyo Press), pp. 655670.
  • Potaman, V.N., Alfeeva, L.Y., Kamensky, A.A., and Nezavibatko, V.N. (1993). Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Peptides 14, 491495.
  • Robbins, L.S., Nadeau, J.H., Johnson, K.R., Kelly, M.A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K.G., and Cone, R.D. (1993). Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827834.
  • Sarkar-Agrawal, P., Vergilis, I., Sharpless, N.E., DePinho, R.A., and Runger, T.M. (2004). Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF. J. Natl Cancer Inst. 96, 17901793.
  • Scott, M.C., Wakamatsu, K., Ito, S. et al. (2002). Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 23492355.
  • Smit, N.P.M., Vink, A.A., Kolb, R.M., Steenwinkel, M.-J.S.T., Van Den Berg, P.T.M., Van Nieuwpoort, F., Roza, L., and Pavel, S. (2001). Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem. Photobiol. 74, 424430.
  • Smith, A.G., Luk, N., Newton, R.A., Roberts, D.W., Sturm, R.A., and Muscat, G.E. (2008). Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J. Biol. Chem. 283, 1256412570.
  • Sober, A.J., Lew, R.A., Koh, H.K., and Barnhill, R.L. (1991). Epidemiology of cutaneous melanoma. An update. Dermatol. Clin. 9, 617629.
  • Suzuki, I., Cone, R., Im, S., Nordlund, J., and Abdel-Malek, Z. (1996). Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137, 16271633.
  • Tadokoro, T., Kobayashi, N., Zmudzka, B.Z., Ito, S., Wakamatsu, K., Yamaguchi, Y., Korossy, K.S., Miller, S.A., Beer, J.Z., and Hearing, V.J. (2003). UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J. 17, 11771179.
  • Yang, Y., Dickinson, C., Haskell-Luevano, C., and Gantz, I. (1997). Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 272, 2300023010.